Cargando…
Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
BACKGROUND: Apart from active allergen avoidance, immunotherapy is regarded as the most effective form of treatment available for type I allergies. Such treatments involve the administration of allergen preparations in various forms and by various routes. Virus-like particles (VLPs) offer a very eff...
Autores principales: | Klimek, Ludger, Kündig, Thomas, Kramer, Matthias F., Guethoff, Sonja, Jensen-Jarolim, Erika, Schmidt-Weber, Carsten B., Palomares, Oskar, Mohsen, Mona O., Jakob, Thilo, Bachmann, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267129/ https://www.ncbi.nlm.nih.gov/pubmed/30546996 http://dx.doi.org/10.1007/s40629-018-0074-y |
Ejemplares similares
-
Schwere Zeiten werfen ihre Schatten auch auf die Allergologie
por: Klimek, Ludger, et al.
Publicado: (2022) -
The impact of allergen exposure and specific immunotherapy on circulating blood cells in allergic rhinitis
por: Jordakieva, Galateja, et al.
Publicado: (2018) -
Is The Allergen Really Needed in Allergy Immunotherapy?
por: Kündig, Thomas M., et al.
Publicado: (2014) -
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
por: Ruzzi, Francesca, et al.
Publicado: (2023) -
Aluminium in Allergies and Allergen immunotherapy
por: Jensen-Jarolim, Erika
Publicado: (2015)